(Q35063817)

6 August 2017

Epidermal growth factor receptor-targeted therapy in locally advanced or metastatic squamous cell carcinoma of the penis (English)

1 reference

metastatic squamous cell carcinoma

6 August 2017

1 reference

Bradley C Carthon

1

1 reference

6 August 2017

Chaan S Ng

series ordinal

2

1 reference

6 August 2017

Curtis A Pettaway

series ordinal

3

1 reference

6 August 2017

Lance C Pagliaro

series ordinal

4

1 reference

6 August 2017

1 June 2014

1 reference

6 August 2017

1 reference

6 August 2017

113

1 reference

6 August 2017

6

1 reference

6 August 2017

871-877

1 reference

EGFR mutational status in penile cancer.

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4321685

The role of human papillomavirus infection in the pathogenesis of penile squamous cell carcinomas

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4321685

Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4321685

EGFR overexpression in squamous cell carcinoma of the penis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4321685

Multimodality therapy in penile cancer: when and which treatments?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4321685

A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992).

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4321685

Penile carcinoma: a challenge for the developing world

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4321685

Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4321685

Proof of activity of anti-epidermal growth factor receptor-targeted therapy for relapsed squamous cell carcinoma of the penis.

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FBJU.12450

PIK3CA, HRAS and KRAS gene mutations in human penile cancer.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FBJU.12450

Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes

21 January 2018

1 reference

12 December 2020

[Characterization of the EGF receptor status in penile cancer : retrospective analysis of the course of the disease in 45 patients]

1 reference

12 December 2020

Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma

1 reference

12 December 2020

Penile cancer: incremental insights into etiology, diagnosis, staging, and management

1 reference

12 December 2020

Prognostic factors in node-positive carcinoma of the penis

1 reference

12 December 2020

Phase II Study of Cetuximab As First-Line Single-Drug Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin

1 reference

12 December 2020

Identifiers

DOI

10.1111/BJU.12450

1 reference

6 August 2017

1 reference

6 August 2017

1 reference